Table 4 Cat owner ectoparasiticide purchases with and without gaps
From: Analysis of gaps in feline ectoparasiticide purchases from veterinary clinics in the United States
Doses purchased | Fluralanera (n = 27,138) | Fipronil/s)-methoprene/pyriproxyfen (n = 10,171) | Imidacloprid/pyriproxyfen (n = 3480) | Selamectin (n = 74,064) |
|---|---|---|---|---|
1 dose Total N (% of total) | 18,265 (67%) | 3609 (35%) | 1903 (55%) | 28,044 (38%) |
2–12 doses (%) | (33%) | (65%) | (45%) | (62%) |
Total purchasing > 1 dose | 8873 | 6562 | 1577 | 46,020 |
No Gap N (%) | 3699 (42%) | 4950 (75%) | 975 (62%) | 31,587 (69%) |
urchase Gap N (%) | 5174 (58%) | 1612 (25%) | 602 (38%) | 14,433 (31%) |
Purchased ≥ 2 doses | 8873 | 6562 | 1577 | 46,020 |
Total with 1–2 dose gap | 4301 | 848 | 395 | 8429 |
% with gap | 48% | 13% | 25% | 18% |
Ave. Gap (Weeks) | 11.2 | 13.9 | 13.3 | 12.9 |
Purchased ≥ 3 doses | 3657 | 5220 | 1110 | 36,818 |
Total with 2–3 dose gap | 1730 | 485 | 238 | 4183 |
% with gap | 47% | 9% | 21% | 11% |
Ave. Gap (Weeks) | 7.7 | 12.2 | 10.0 | 10.2 |
Purchased ≥ 4 doses | 1671 | 3374 | 871 | 28,463 |
Total with 3–4 dose gap | 647 | 373 | 113 | 3262 |
% with gap | 39% | 11% | 13% | 11% |
Ave. Gap (Weeks) | 4.5 | 12.7 | 10.2 | 10.2 |
Purchased ≥ 5 doses | 407 | 2411 | 600 | 25,581 |
Total with 4–5 dose gap | 103 | 239 | 107 | 1625 |
% with gap | 25% | 10% | 18% | 6% |
Ave. Gap (Weeks) | 2.5 | 10.1 | 11.1 | 8.2 |
Purchased ≥ 6 doses | 2200 | 533 | 24,189 | |
Total with 5–6 dose gap | 79 | 37 | 833 | |
% with gap | 4% | 7% | 3% | |
Ave. Gap (Weeks) | 6.6 | 5.7 | 5.6 | |
Purchased ≥ 7 doses | 1155 | 236 | 12,029 | |
Total with 6–7 dose gap | 134 | 36 | 2164 | |
% with gap | 12% | 15% | 18% | |
Ave. Gap (Weeks) | 10.0 | 9.0 | 9.1 | |
Purchased ≥ 8 doses | 1014 | 199 | 10,445 | |
Total with 7–8 dose gap | 42 | 7 | 428 | |
% with gap | 4% | 4% | 4% | |
Ave. Gap (Weeks) | 5.9 | 3.0 | 4.3 | |
Purchased ≥ 9 doses | 603 | 105 | 7327 | |
Total with 8–9 dose gap | 35 | 8 | 361 | |
% with gap | 6% | 8% | 5% | |
Ave. Gap (Weeks) | 6.2 | 3.3 | 5.4 | |
Purchased ≥ 10 doses | 339 | 89 | 5732 | |
Total with 9–10 dose gap | 23 | 5 | 276 | |
% with gap | 7% | 6% | 5% | |
Ave. Gap (Weeks) | 5.6 | 5.6 | 4.4 | |
Purchased ≥ 11 doses | 289 | 77 | 5206 | |
Total with 10–11 dose gap | 5 | 3 | 131 | |
% with gap | 2% | 4% | 3% | |
Ave. Gap (Weeks) | 3.8 | 2.3 | 3.2 | |
Purchased 12 doses | 251 | 69 | 4845 | |
Total with 11–12 dose gap | 2 | 1 | 40 | |
% with gap | 1% | 1% | 1% | |
Ave. Gap (Weeks) | 2.0 | 1.0 | 2.7 |